CTRI/2017/03/008184已完成2 期
A Prospective, Multi-centric, Randomized, Double-blind, Parallel, Saline Controlled Phase II Safety and Efficacy study of PMZ-2010 as a resuscitative agent for Hypovolemic Shock dueto excessive blood loss to be used along with standard shock treatment.
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a. Adult males or females aged 18-60 years.
- •b.Patients with Hypovolemic shock due to blood loss admitted to the emergency room or ICU with systolic blood pressure <90 mmHg even after 10 min of standard shock treatment (endotracheal intubation; fluid resuscitation and vasopressors). Standard care to be provided to the patients shall be the one used in the particular hospital setup.
- •c.Body weight 45 kg â?? 85 kg
- •d. Estimated time from injury to randomization <4 hours
- •e. Subject is <4 hours from time of Hypovolemic shock onset when the first dose of PMZ-2010 therapy is administered. Time of onset is when symptoms began; Reasonable expectation of availability to receive the full PMZ-2010 course of therapy, and to be available for subsequent follow-up visits
- •f. Female subject is either:
- •Not of childbearing potential, defined as postmenopausal for at least 1 year or surgically sterile (bilateral tubal ligation, bilateral oophorectomy or hysterectomy)
- •If of childbearing potential, agrees to use any of the following effective separate forms of contraception throughout the study, up to and including the follow-up visits: Condoms, sponge, foams, jellies, diaphragm or intrauterine device, or A vasectomised partner OR abstinence
排除标准
- •a. Terminal illness
- •b. Development of any other terminal illness not associated with Hypovolemic shock during the 28 day observation period.
- •c. Evidence of severe blunt or penetrating head injury with a Glasgow Coma Scale (GCS) <= 8
- •d. Type of injury is not known
- •e. Inability to obtain intravenous access
- •f.Known pregnancy
- •g. Cardiopulmonary resuscitation (CPR) before randomization
- •h. Presence of a do not resuscitate order
- •i. Patient taking beta adrenergic antagonists
- •j. Untreated tension pneumothorax
- •k. Untreated cardiac tamponade
- •l.Bilateral absent pupillary light reflex (both pupils fixed and dilated)
- •m. Patient is participating in another interventional study
- •n.Presence of systemic diseases (cancer, chronic renal failure, liver failure, decompensated heart failure or AIDS)
- •o.Patients with triad of coagulopathy, acidosis and hypothermia that requires immediate blood transfusion
研究者
相似试验
尚未招募
不适用
A Clinical study to evaluate the Safety and Efficacy of CurQfen in mild to moderate Knee Osteoarthritis Patients.CTRI/2019/03/017954Akay Flavours and Aromatics Private Limited
已完成
2 期
To Study the effect of PMZ-1620 in stroke patients.CTRI/2017/11/010654Pharmazz India Private Limited40
进行中(未招募)
2 期
Effect of PMZ-1620 in Alzheimers disease.CTRI/2017/12/011003Pharmazz India Private Limited80
尚未招募
2 期
To Study the effect of PMZ-1620 in spinal cord injury patients.CTRI/2018/12/016667Pharmazz India Private Limited
已完成
3 期
Effect of PMZ-2010 in Hypovolemic Shock patients.CTRI/2019/01/017196Pharmazz India Private Limited105
